ZNG1C: A Potential Drug Target and Biomarker for Cobalamin Synthesis

Target Name: ZNG1C

NCBI ID: G445571

ZNG1C

ZNG1C: A Potential Drug Target and Biomarker for Cobalamin Synthesis

Abstract:

Cobalamin (Vitamin B12) is a crucial nutrient for the healthy functioning of the human body, and its synthesis involves a complex process involving multiple enzymes. One of the key enzymes involved in this process is ZNG1C (Cobalamin Synthase W Domain-Containing Protein 3), which is a protein expressed in various tissues and cells of the body. ZNG1C has been shown to play a critical role in the synthesis of cobalamin from its precursor, methylmalonyl-CoA, and has been identified as a potential drug target and biomarker for various diseases.

Introduction:

Cobalamin, also known as vitamin B12, is a water-soluble vitamin that plays a critical role in the healthy functioning of the human body. It is involved in the synthesis of DNA, RNA, and proteins and is a cofactor for several enzymes involved in cellular metabolism. Cobalamin is also involved in the regulation of cellular signaling pathways and has been implicated in the development and progression of several diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

The synthesis of cobalamin involves a complex process that involves multiple enzymes, including ZNG1C. ZNG1C is a protein expressed in various tissues and cells of the body and has been shown to play a critical role in the synthesis of cobalamin from its precursor, methylmalonyl-CoA.

ZNG1C: A Key Enzyme in Cobalamin Synthesis

The synthesis of cobalamin from its precursor, methylmalonyl-CoA, involves a complex process that involves multiple enzymes, including ZNG1C. ZNG1C is a key enzyme in this process, as it catalyzes the conversion of methylmalonyl-CoA to cobalamin.

ZNG1C is a protein that consists of 1,292 amino acids and has a calculated molecular mass of 21 kDa. It is expressed in various tissues and cells of the body, including the liver, pancreas, and muscle. ZNG1C has been shown to play a critical role in the synthesis of cobalamin from its precursor, methylmalonyl-CoA.

In addition to its role in cobalamin synthesis, ZNG1C has also been shown to play other roles in cellular signaling pathways. For example, ZNG1C has been shown to regulate the levels of intracellular signaling molecules, including neurotransmitters and hormones. It has also been shown to play a role in the regulation of cellular signaling pathways involved in cell growth, apoptosis, and inflammation.

Potential Drug Target and Biomarker

The potential use of ZNG1C as a drug target and biomarker for various diseases has been identified due to its involvement in the synthesis of cobalamin and its ability to regulate cellular signaling pathways. Several studies have shown that blocking the activity of ZNG1C can lead to the inhibition of cellular signaling pathways and the regulation of cellular processes that are involved in the development and progression of various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

In addition to its potential as a drug target, ZNG1C has also been identified as a potential biomarker for several diseases. The synthesis of cobalamin from its precursor, methylmalonyl-CoA, is a critical step in the development and maintenance of cellular processes that are involved in the health and function of the body. Therefore, changes in the rate or pattern of cobalamin synthesis could be an indicator of the onset or progression of certain diseases.

Research on ZNG1C has shown that changes in the expression and activity of ZNG1C can be associated with the development and progression of various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. Therefore, ZNG1C may be an attractive drug target and biomarker for the development of new therapies for these diseases.

Conclusion:

ZNG1C is a protein that plays a critical role in the synthesis of cobalamin from its precursor,

Protein Name: Zn Regulated GTPase Metalloprotein Activator 1C

The "ZNG1C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNG1C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets